Reactive thrombocytosis following coronary artery bypass surgery: A possible link to a lipid dysfunction

Journal of Cardiovascular Surgery

Volumn 37, Issue 5, 1996, Pages 491-498

  Christenson, J T ^a   Gras, P A ^a   Grosclaude, A ^a   Simonet, F ^a   Schmuziger, M ^a  

^a LA TOUR HOSPITAL   (Switzerland)

Author keywords

Acetylsalicylic acid; Cardiopulmonary bypass; Cholesterol; Coronary artery bypass grafting; Heart surgery; Thrombocytosis

Indexed keywords

ACETYLSALICYLIC ACID; CHOLESTEROL; COUMARIN; HEPARIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HUMAN; MALE; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; THROMBOCYTOSIS;

ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; CORONARY ARTERY BYPASS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; THROMBOCYTOSIS;

EID: 0029957221     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. McKenzie FN, Dhall DP, Arfors K-E, Nordlund S, Matheson NA. Blood platelet behaviour during and after open-heart surgery Br J Med 1969;795-8.
2. Schmuziger M, Christenson JT, Maurice J, Simonet F, Velebit V Reactive thrombocytosis after coronary bypass surgery An important risk factor. Eur J Cardio-thorac Surg 1995,9:393-8
3. Hamada Y, Matsuda Y, Fujii B et al Multiple coronary thrombosis in a patient with thrombocytosis. Clin Cardiol 1989;12:723-4.
4. Kannel WB, Castelli WP, McNamara PM The coronary profile: 12-year follow-up in the Framingham study J Med 1967; 9:611-8.
5. Roberts WC. Does thrombosis pay a major role in the development of symptom-producing atherosclerotic plaques? Circulation 1973;48:1161-4.
6. Harker LA, Slichter SJ. Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves. N Engl J Med 1974;283;1302-7
7. Ritchie JL, Harker LA Platelet and fibrinogen survival in coronary atherosclerosis. Response to medical and surgical therapy. Am J Cardiol 1977;39:595-9.
8. Nordoy A, Rodset JM. Platelet phospholipids and their function in patients with ischemic heart disease. Acta Med Scand 1970;188:133-6.
9. Carvalho AC, Colman RW, Lees RS. Platelet function in hyperlipoproteinemia. N Engl J Med 1974;290:434-8.
10. Shattil SJ, Anaya-Galindo R, Bennett J, Colman RW, Cooper RA. Platelet hypersensitivity induced by cholesterol incorporation. J Clin Invest 1975;55:636-41.
11. Steele P, Rainwater J. Effects of dietry and pharmacologic alteration of serum lipids on platelet survival Circulation 1978;58:365-7
12. Salky N, Dugdale M Platelet abnormalities in ischemic heart disease. Am J Cardiol 1973;32:612-7.
13. Uterman G. The mysteries of lipoprotein(a). Science 1989;246:904-10.
14. Liu A, Lawn RM. Lipoprotein(a) and artherogenesis. Trends Cardiovasc Med 1994;4:40-4.
15. Lackner C, Boerwinkle E, Leffert C, Rahmig T, Hobbs HH. Molecular basis of apolipoprotein(a) isofrom size heterogeneity as revealed by pulsed-field gel electrophoresis J Clin Invest 1991,87:2077-86
16. Albers JJ, Marcovina SM, Lodge MS The unique lipoprotein(a) properties and immunochemical measurement. Clin Chem 1990;36 2019-26.
17. Sandholzer C, Hallman E, Saha N et al. Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum Genet 1991;86:607-14.
18. Dahlén GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto Am Jr. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986;74:758-65
19. Moliterno DJ, Jokinen EV, Miserez AR et al No association between plasma lipoprotein(a) concentrations and the presence or absence of coronary artherosclerosis in African-Americans. Arterioscler Thromb Vasc Biol 1995;15:850-5.
20. Fruchart JC. Lp(a): Facteur de risque cardiovasculaire? Proc Hémostase et Maladies Cardiovasculaires, Sept. 29-30, 1994, Nancy, France.
21. Hajjar KA, Gavish D, Breslow JL, Nachman RL. Lipoprotein (a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 1989;339:303-5.
22. Ballentyne CM, Chan L, Guevara J, Morrisett JD, Mims MP, Gotto Jr AM. Recent advances in lipoprotein and atherosclerosis research at Baylor College of Medicine. Apolipoprotein B, Lipoprotein(a) and transplantation arteriopathy. Texas Heart Inst J 1994;21:48-55.
23. Senning A. Plasma-heparin concentration in extracorporeal circulation. Acta Chir Scand 1959;117:55-9.
24. Horkay F, Martin P, Rajah SM, Walker DR. Response to heparinization in adults and children undergoing cardiac operations. Ann Thorac Surg 1992;53:822-6.
25. Turner-Gomes SO, Andrew M, Coles J, Trusler GA, Williams WG, Rabinovitch M. Abnormalities in von Willebrand factor and antithrombin III after cardiopulmonary bypass operations for congenital heart disease. J Thorac Cardiovasc Surg 1992; 103:87-97
26. Hashimoto K, Yamagishi M, Sasaki T, Nakano M, Kurosawa H Heparin and antithrombin III levels during cardiopulmonary bypass: correlation with sublicnical plasma coagulation. Ann Thorac Surg 1994;58:799-805.